TY - JOUR
T1 - The effect of survival bias on case-control genetic association studies of highly lethal diseases
AU - Anderson, Christopher D.
AU - Nalls, Michael A.
AU - Biffi, Alessandro
AU - Rost, Natalia S.
AU - Greenberg, Steven M.
AU - Singleton, Andrew B.
AU - Meschia, James F.
AU - Rosand, Jonathan
PY - 2011/4
Y1 - 2011/4
N2 - Background: Survival bias is the phenomenon by which individuals are excluded from analysis of a trait because of mortality related to the expression of that trait. In genetic association studies, variants increasing risk for disease onset as well as risk of disease-related mortality (lethality) could be difficult to detect in genetic association case-control designs, possibly leading to underestimation of a variant's effect on disease risk. Methods and Results: We modeled cohorts for 3 diseases of high lethality (intracerebral hemorrhage, ischemic stroke, andmyocardial infarction) using existing longitudinal data. Based on these models, we simulated case-control genetic association studies for genetic risk factors of varying effect sizes, lethality, and minor allele frequencies. For each disease, erosion of detected effect size was larger for case-control studies of individuals of advanced age (age >75 years) and/or variants with very high event-associated lethality (genotype relative risk for event-related death >2.0). We found that survival bias results in no more than 20% effect size erosion for cohorts with mean age <75 years, even for variants that double lethality risk. Furthermore, we found that increasing effect size erosion was accompanied by depletion of minor allele frequencies in the case population, yielding a " signature" of the presence of survival bias. Conclusions: Our simulation provides formulas to allow estimation of effect size erosion given a variant's odds ratio of disease, odds ratio of lethality, and minor allele frequencies. These formulas will add precision to power calculation and replication efforts for case-control genetic studies. Our approach requires validation using prospective data.
AB - Background: Survival bias is the phenomenon by which individuals are excluded from analysis of a trait because of mortality related to the expression of that trait. In genetic association studies, variants increasing risk for disease onset as well as risk of disease-related mortality (lethality) could be difficult to detect in genetic association case-control designs, possibly leading to underestimation of a variant's effect on disease risk. Methods and Results: We modeled cohorts for 3 diseases of high lethality (intracerebral hemorrhage, ischemic stroke, andmyocardial infarction) using existing longitudinal data. Based on these models, we simulated case-control genetic association studies for genetic risk factors of varying effect sizes, lethality, and minor allele frequencies. For each disease, erosion of detected effect size was larger for case-control studies of individuals of advanced age (age >75 years) and/or variants with very high event-associated lethality (genotype relative risk for event-related death >2.0). We found that survival bias results in no more than 20% effect size erosion for cohorts with mean age <75 years, even for variants that double lethality risk. Furthermore, we found that increasing effect size erosion was accompanied by depletion of minor allele frequencies in the case population, yielding a " signature" of the presence of survival bias. Conclusions: Our simulation provides formulas to allow estimation of effect size erosion given a variant's odds ratio of disease, odds ratio of lethality, and minor allele frequencies. These formulas will add precision to power calculation and replication efforts for case-control genetic studies. Our approach requires validation using prospective data.
KW - Epidemiology
KW - Genetics
KW - Hemorrhage
KW - Myocardial infarction
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=79959743115&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959743115&partnerID=8YFLogxK
U2 - 10.1161/CIRCGENETICS.110.957928
DO - 10.1161/CIRCGENETICS.110.957928
M3 - Article
C2 - 21292865
AN - SCOPUS:79959743115
SN - 1942-325X
VL - 4
SP - 188
EP - 196
JO - Circulation: Cardiovascular Genetics
JF - Circulation: Cardiovascular Genetics
IS - 2
ER -